|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
5F30CA210539-02
|
$44,044
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Chemotherapy-induced MDSCs and antitumor immunity
|
1R01CA215523-01
|
$347,700
|
ZHOU, GANG
|
AUGUSTA UNIVERSITY
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
1R01CA213138-01
|
$395,738
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
1R21CA205106-01A1
|
$234,992
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Risk factors for molecular subtypes of NHL a prospective evaluation
|
5R01CA202712-02
|
$830,007
|
WANG, SOPHIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-04
|
$312,304
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
|
5R01CA161151-05
|
$381,305
|
YAN, CATHERINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
|
5R01CA196703-03
|
$404,888
|
CHIARLE, ROBERTO
|
BOSTON CHILDREN'S HOSPITAL
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Transforming the diagnosis and care of patients with CTCL using TCR sequencing
|
5R01CA203721-02
|
$680,545
|
CLARK, RACHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
|
2R01CA047006-30
|
$532,500
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-05
|
$393,163
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CAR-T cell control through orthogonal antibody-based switches
|
5R01CA208398-02
|
$411,782
|
YOUNG, TRAVIS
|
CALIFORNIA INSTITUTE/BIOMEDICAL RESEARCH
|
|
Impact of social and built environments on health-related quality of life for cancer survivors
|
5R03CA202192-02
|
$74,500
|
SHARIFF-MARCO, SALMA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Phase I trial combining IV fenretinide and IV safingol to target overproduction
|
4R44CA183316-02
|
$648,029
|
SIMPSON, WILLIAM
|
CERRX, INC.
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-06
|
$269,433
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
|
5R01CA187415-03
|
$448,485
|
LI, YONG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
3P01CA013106-45S1
|
$2,165,000
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL Cancer Center Support Grant
|
5P30CA045508-30
|
$4,395,404
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
Identification of Loci Modifying Atm Lymphomagenesis
|
5R01CA197801-03
|
$343,463
|
WEIL, MICHAEL
|
COLORADO STATE UNIVERSITY
|
|
Roles and Regulation of wild-type and mutant forms of p53
|
2P01CA087497-16A1
|
$1,945,587
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Defining the functions and translational potential of ferroptosis
|
5R35CA209896-02
|
$955,184
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
|
5R35CA210105-02
|
$960,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
DNA double-strand break repair, chromosomes translocations and cancer
|
5P01CA174653-04
|
$1,778,566
|
GAUTIER, JEAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms of targeting oncoprotein SET in tumor suppression
|
1R01CA216884-01
|
$366,000
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Regulation of p53 acetylation and deacetylation in tumorigenesis
|
5R01CA085533-14
|
$288,000
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Regulation of SLC7A11 by p53 in cancer metabolism
|
5R01CA190477-02
|
$366,000
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
HAUSP inhibitors in p53-wild type and p53-mutant tumors
|
5R01CA193890-03
|
$366,000
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|